These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21240977)

  • 1. Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations.
    Bell GH; Novak AJ; Griffin WC; Patrick KS
    J Pharm Sci; 2011 Jul; 100(7):2966-78. PubMed ID: 21240977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.
    Patrick KS; Corbin TR; Murphy CE
    J Pharm Sci; 2014 Dec; 103(12):3834-3842. PubMed ID: 25303048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers.
    Zhu HJ; Patrick KS; Straughn AB; Reeves OT; Bernstein H; Shi J; Johnson HJ; Knight JM; Smith AT; Malcolm RJ; Markowitz JS
    J Clin Psychopharmacol; 2017 Aug; 37(4):419-428. PubMed ID: 28590363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics.
    Patrick KS; Straughn AB; Minhinnett RR; Yeatts SD; Herrin AE; DeVane CL; Malcolm R; Janis GC; Markowitz JS
    Clin Pharmacol Ther; 2007 Mar; 81(3):346-53. PubMed ID: 17339864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral and transdermal DL-methylphenidate-ethanol interactions in C57BL/6J mice: potentiation of locomotor activity with oral delivery.
    Bell GH; Griffin WC; Patrick KS
    Pharmacol Biochem Behav; 2011 Dec; 100(2):264-70. PubMed ID: 21925201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of stimulants to treat ADHD: transdermal methylphenidate.
    Patrick KS; Straughn AB; Perkins JS; González MA
    Hum Psychopharmacol; 2009 Jan; 24(1):1-17. PubMed ID: 19051222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humans.
    Patrick KS; Straughn AB; Reeves OT; Bernstein H; Bell GH; Anderson ER; Malcolm RJ
    Drug Metab Dispos; 2013 Jan; 41(1):197-205. PubMed ID: 23104969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity.
    Williard RL; Middaugh LD; Zhu HJ; Patrick KS
    Behav Pharmacol; 2007 Feb; 18(1):39-51. PubMed ID: 17218796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantiospecific determination of DL-methylphenidate and DL-ethylphenidate in plasma by liquid chromatography-tandem mass spectrometry: application to human ethanol interactions.
    Zhu HJ; Patrick KS; Markowitz JS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):783-8. PubMed ID: 21402502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of application to two different skin sites on the pharmacokinetics of transdermal methylphenidate in pediatric patients with attention-deficit/hyperactivity disorder.
    González MA; Campbell D; Rubin J
    J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):227-32. PubMed ID: 19519257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-dose, two-way crossover, bioequivalence study of dexmethylphenidate HCl with and without food in healthy subjects.
    Teo SK; Scheffler MR; Wu A; Stirling DI; Thomas SD; Stypinski D; Khetani VD
    J Clin Pharmacol; 2004 Feb; 44(2):173-8. PubMed ID: 14747426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system.
    Heal DJ; Pierce DM
    CNS Drugs; 2006; 20(9):713-38. PubMed ID: 16953648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study.
    Pierce D; Dixon CM; Wigal SB; McGough JJ
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):355-64. PubMed ID: 18759645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single- and multiple-dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic-release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder.
    Pierce D; Katic A; Buckwalter M; Webster K
    J Clin Psychopharmacol; 2010 Oct; 30(5):554-64. PubMed ID: 20814325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children.
    Anderson VR; Scott LJ
    Drugs; 2006; 66(8):1117-26. PubMed ID: 16789796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for Underestimation of d-Methylphenidate Bioavailability Using Chiral Derivatization/Gas Chromatography.
    Patrick KS; Rodriguez W
    Drug Metab Dispos; 2019 Jul; 47(7):764-767. PubMed ID: 31028056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Ethanol-Induced Potentiation of Stimulatory Responses to Dexmethylphenidate Versus Methylphenidate.
    Patrick KS; Straughn AB; Reeves OT; Bernstein H; Malcolm R
    J Clin Psychopharmacol; 2015 Aug; 35(4):464-7. PubMed ID: 26075488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man.
    Tuerck D; Wang Y; Maboudian M; Wang Y; Sedek G; Pommier F; Appel-Dingemanse S
    Int J Clin Pharmacol Ther; 2007 Dec; 45(12):662-8. PubMed ID: 18184535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.